
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (20): 2457-2461.DOI: 10.12114/j.issn.1007-9572.2022.0089
Special Issue: 内分泌代谢性疾病最新文章合辑; 肥胖/减重最新文章合辑
• Article • Previous Articles Next Articles
Received:2021-12-23
Revised:2022-03-01
Published:2022-07-15
Online:2022-03-24
Contact:
Lianxi LI
About author:
通讯作者:
李连喜
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0089
| 项目 | T2DM无肥胖组(n=1 609) | T2DM肥胖组(n=1 414) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 年龄(岁) | 59±13 | 58±13 | 2.110a | 0.441 |
| 性别(男/女) | 904/705 | 816/598 | 0.713b | 0.398 |
| 糖尿病病程〔M(P25,P75),月〕 | 84(16,144) | 72(24,132) | -0.600 | 0.879 |
| 吸烟史〔n(%)〕 | 466(29.0) | 426(30.1) | 0.491b | 0.483 |
| 饮酒史〔n(%)〕 | 231(14.4) | 255(18.0) | 7.542b | 0.006 |
| 高血压病史〔n(%)〕 | 735(45.7) | 857(60.6) | 67.274b | <0.001 |
| 降压药用药史〔n(%)〕 | 650(40.4) | 805(56.9) | 82.401b | <0.001 |
| 收缩压(mm Hg) | 130±17 | 134±17 | 6.455a | <0.001 |
| 舒张压(mm Hg) | 79±9 | 82±10 | 8.681a | <0.001 |
| 腰臀比 | 0.89±0.06 | 0.94±0.06 | 22.861a | <0.001 |
| FPG〔M(P25,P75),mmol/L〕 | 7.53(6.00,9.65) | 7.91(6.51,9.89) | -4.152 | <0.001 |
| 2 hPG〔M(P25,P75),mmol/L〕 | 13.14(9.43,16.49) | 13.93(10.88,17.05) | -5.686 | <0.001 |
| Scr〔M(P25,P75),μmol/L〕 | 65(54,78) | 68(57,82) | -4.073 | 0.007 |
| HbA1c(%) | 9.25±2.52 | 9.02±2.23 | 2.641a | 0.018 |
| 空腹C肽〔M(P25,P75),μmol/L〕 | 1.37(0.76,2.02) | 1.98(1.33,2.83) | -16.444 | <0.001 |
| 餐后2 hC肽〔M(P25,P75),μmol/L〕 | 2.96(1.48,4.80) | 4.29(2.72,5.65) | -14.447 | <0.001 |
| TG〔M(P25,P75),mmol/L〕 | 1.22(0.86,1.78) | 1.73(1.21,2.49) | -16.610 | <0.001 |
| TC(mmol/L) | 4.63±1.15 | 4.78±1.12 | 3.622a | <0.001 |
| HDL(mmol/L) | 1.18±0.33 | 1.04±0.27 | 12.658a | <0.001 |
| LDL(mmol/L) | 3.04±0.98 | 3.13±0.90 | 2.617a | 0.007 |
| ALT〔M(P25,P75),U/L〕 | 17(12,25) | 23(15,37) | -11.595 | <0.001 |
| 血尿酸〔M(P25,P75),μmol/L〕 | 291(241,348) | 337(276,397) | -12.760 | <0.001 |
Table 1 Comparison of general clinical features between T2DM patients without and with obesity
| 项目 | T2DM无肥胖组(n=1 609) | T2DM肥胖组(n=1 414) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 年龄(岁) | 59±13 | 58±13 | 2.110a | 0.441 |
| 性别(男/女) | 904/705 | 816/598 | 0.713b | 0.398 |
| 糖尿病病程〔M(P25,P75),月〕 | 84(16,144) | 72(24,132) | -0.600 | 0.879 |
| 吸烟史〔n(%)〕 | 466(29.0) | 426(30.1) | 0.491b | 0.483 |
| 饮酒史〔n(%)〕 | 231(14.4) | 255(18.0) | 7.542b | 0.006 |
| 高血压病史〔n(%)〕 | 735(45.7) | 857(60.6) | 67.274b | <0.001 |
| 降压药用药史〔n(%)〕 | 650(40.4) | 805(56.9) | 82.401b | <0.001 |
| 收缩压(mm Hg) | 130±17 | 134±17 | 6.455a | <0.001 |
| 舒张压(mm Hg) | 79±9 | 82±10 | 8.681a | <0.001 |
| 腰臀比 | 0.89±0.06 | 0.94±0.06 | 22.861a | <0.001 |
| FPG〔M(P25,P75),mmol/L〕 | 7.53(6.00,9.65) | 7.91(6.51,9.89) | -4.152 | <0.001 |
| 2 hPG〔M(P25,P75),mmol/L〕 | 13.14(9.43,16.49) | 13.93(10.88,17.05) | -5.686 | <0.001 |
| Scr〔M(P25,P75),μmol/L〕 | 65(54,78) | 68(57,82) | -4.073 | 0.007 |
| HbA1c(%) | 9.25±2.52 | 9.02±2.23 | 2.641a | 0.018 |
| 空腹C肽〔M(P25,P75),μmol/L〕 | 1.37(0.76,2.02) | 1.98(1.33,2.83) | -16.444 | <0.001 |
| 餐后2 hC肽〔M(P25,P75),μmol/L〕 | 2.96(1.48,4.80) | 4.29(2.72,5.65) | -14.447 | <0.001 |
| TG〔M(P25,P75),mmol/L〕 | 1.22(0.86,1.78) | 1.73(1.21,2.49) | -16.610 | <0.001 |
| TC(mmol/L) | 4.63±1.15 | 4.78±1.12 | 3.622a | <0.001 |
| HDL(mmol/L) | 1.18±0.33 | 1.04±0.27 | 12.658a | <0.001 |
| LDL(mmol/L) | 3.04±0.98 | 3.13±0.90 | 2.617a | 0.007 |
| ALT〔M(P25,P75),U/L〕 | 17(12,25) | 23(15,37) | -11.595 | <0.001 |
| 血尿酸〔M(P25,P75),μmol/L〕 | 291(241,348) | 337(276,397) | -12.760 | <0.001 |
| 项目 | 赋值 | 项目 | 赋值 |
|---|---|---|---|
| 年龄 | 实测值 | 2 hPG | 实测值 |
| 性别 | 男=0,女=1 | Scr | 实测值 |
| 糖尿病病程 | 实测值 | HbA1c | 实测值 |
| 吸烟史 | 不吸烟=0,吸烟=1 | 空腹C肽 | 实测值 |
| 饮酒史 | 不饮酒=0,饮酒=1 | 餐后2 hC肽 | 实测值 |
| 高血压病史 | 无=0,有=1 | TG | 实测值 |
| 降压药用药史 | 无=0,有=1 | TC | 实测值 |
| 收缩压 | 实测值 | HDL | 实测值 |
| 舒张压 | 实测值 | LDL | 实测值 |
| 腰臀比 | 实测值 | ALT | 实测值 |
| FPG | 实测值 | 血尿酸 | 实测值 |
Table 2 Assignment for variables possibly,independently associated with the correlation between obesity and albuminuria in T2DM patients assessed using binary Logistic regression analysis
| 项目 | 赋值 | 项目 | 赋值 |
|---|---|---|---|
| 年龄 | 实测值 | 2 hPG | 实测值 |
| 性别 | 男=0,女=1 | Scr | 实测值 |
| 糖尿病病程 | 实测值 | HbA1c | 实测值 |
| 吸烟史 | 不吸烟=0,吸烟=1 | 空腹C肽 | 实测值 |
| 饮酒史 | 不饮酒=0,饮酒=1 | 餐后2 hC肽 | 实测值 |
| 高血压病史 | 无=0,有=1 | TG | 实测值 |
| 降压药用药史 | 无=0,有=1 | TC | 实测值 |
| 收缩压 | 实测值 | HDL | 实测值 |
| 舒张压 | 实测值 | LDL | 实测值 |
| 腰臀比 | 实测值 | ALT | 实测值 |
| FPG | 实测值 | 血尿酸 | 实测值 |
| 模型 | B | SE | OR(95%CI) | Wald χ2值 | P值 |
|---|---|---|---|---|---|
| 模型1 | 0.550 | 0.086 | 1.733(1.463,2.052) | 40.578 | <0.001 |
| 模型2 | 0.377 | 0.090 | 1.458(1.222,1.740) | 17.555 | <0.001 |
| 模型3 | 0.277 | 0.097 | 1.319(1.092,1.594) | 8.238 | 0.004 |
| 模型4 | 0.236 | 0.114 | 1.266(1.013,1.582) | 4.299 | 0.038 |
Table 3 Binary Logistic regression analysis of the correlation between obesity and albuminuria in T2DM patients
| 模型 | B | SE | OR(95%CI) | Wald χ2值 | P值 |
|---|---|---|---|---|---|
| 模型1 | 0.550 | 0.086 | 1.733(1.463,2.052) | 40.578 | <0.001 |
| 模型2 | 0.377 | 0.090 | 1.458(1.222,1.740) | 17.555 | <0.001 |
| 模型3 | 0.277 | 0.097 | 1.319(1.092,1.594) | 8.238 | 0.004 |
| 模型4 | 0.236 | 0.114 | 1.266(1.013,1.582) | 4.299 | 0.038 |
| [1] |
|
| [2] |
|
| [3] |
沈雯雯,刘志红,陈慧梅,等. 肥胖相关性肾病:体重指数与蛋白尿的关系[J]. 肾脏病与透析肾移植杂志,2009,18(6):504-512,547. DOI:10.3969/j.issn.1006-298X.2009.06.002.
|
| [4] |
|
| [5] |
卢锐锋,范婉华. 2型糖尿病患者肥胖不同指标与尿微量白蛋白的相关性研究[J]. 中国实用医药,2019,14(34):104-105. DOI:10.14163/j.cnki.11-5547/r.2019.34.054.
|
| [6] |
周雁,郭立新,于冬妮,等. 1758例2型糖尿病住院患者糖尿病肾病的相关因素分析[J]. 中华流行病学杂志,2012,33(6):610-613. DOI:10.3760/cma.j.issn.0254-6450.2012.06.015.
|
| [7] |
卫生部疾病控制司,中华医学会糖尿病学分会. 《中国糖尿病防治指南》(试行本)(节选)[J]. 中国慢性病预防与控制,2004,12(6):283-285. DOI:10.3969/j.issn.1004-6194.2004.06.022.
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
雷娟,周淑娴,薛声能,等. 微量白蛋白尿与代谢紊乱关系的探讨[J]. 中国临床实用医学,2008,2(3):16-17.
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [1] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [2] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [3] | LI Feng, HU Changhao, LUO Xu. Progress in the Study of Influencing Factors and Intervention Strategies of Mental Health in Elderly Patients with Multiple Chronic Conditions [J]. Chinese General Practice, 2026, 29(20): 2816-2828. |
| [4] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [5] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [6] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| [7] | CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758. |
| [8] | ZHANG Huifang, CHEN Cunchuan, FAN Boyang, SUN Wenning, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study on the Service Capability of Primary Care Doctors to Integrate Medical and Preventive Services and Its Influencing Factors in Shandong Province [J]. Chinese General Practice, 2026, 29(19): 2711-2716. |
| [9] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [10] | LIU Fang, LIU Weinan, XIANG Yuanyue, LU Cheng, ZHU Binhai. Factors Influencing Work-related Flow among "3+2" Order-oriented Assistant General Practitioners in Jiangsu Province [J]. Chinese General Practice, 2026, 29(18): 2454-2460. |
| [11] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [12] | LI Simin, ZHANG Tingting, WANG Kunbo, YANG Jianzhou, PING Weiwei. Effects of Exercise Dosage on Elderly Patients with Sarcopenia: a Meta-analysis [J]. Chinese General Practice, 2026, 29(17): 2400-2409. |
| [13] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [14] | YU Shan, CHE Yajie, SUBIYINUER· Maimaiti, GUO Kaiyang, FENG Xingxing, YAN Ping. A Comparative Study on the Current Situation and Influencing Factors of Subjective Cognitive Decline among Urban and Rural Elderly People in Xinjiang [J]. Chinese General Practice, 2026, 29(16): 2227-2233. |
| [15] | CHEN Bihua, LIN Qiyi, LI Wuhua, SU Jin, TU Liping, SHI Lan, DING Xiaoqin, YI Chuntao. The Influencing Factors and Mechanisms of the Work Output Level of Family Doctor Teams from the Perspective of Team Effectiveness [J]. Chinese General Practice, 2026, 29(16): 2167-2173. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||